Quantbot Technologies LP Purchases 24,789 Shares of MetLife, Inc. $MET

Quantbot Technologies LP increased its position in shares of MetLife, Inc. (NYSE:MET) by 197.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,341 shares of the financial services provider’s stock after buying an additional 24,789 shares during the period. Quantbot Technologies LP’s holdings in MetLife were worth $3,003,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Delta Investment Management LLC lifted its stake in shares of MetLife by 0.9% in the 1st quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock valued at $1,145,000 after purchasing an additional 133 shares during the period. Ignite Planners LLC grew its stake in MetLife by 2.2% during the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after purchasing an additional 136 shares during the period. Legacy Capital Wealth Partners LLC increased its holdings in MetLife by 3.2% in the second quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock worth $350,000 after purchasing an additional 137 shares in the last quarter. Glenview Trust co lifted its stake in MetLife by 0.4% in the first quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock valued at $3,078,000 after buying an additional 141 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of MetLife by 1.0% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 14,902 shares of the financial services provider’s stock worth $1,198,000 after buying an additional 148 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MET opened at $77.97 on Friday. The stock has a 50 day moving average of $78.73 and a 200 day moving average of $78.71. The company has a market capitalization of $51.38 billion, a price-to-earnings ratio of 14.68, a PEG ratio of 0.75 and a beta of 0.76. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $88.09. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The business had revenue of $12.46 billion for the quarter, compared to analysts’ expectations of $18.64 billion. During the same quarter in the previous year, the firm earned $1.95 earnings per share. The business’s revenue was down 5.9% on a year-over-year basis. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be issued a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s payout ratio is 42.75%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on MET shares. Jefferies Financial Group boosted their target price on shares of MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research report on Monday, August 11th. Keefe, Bruyette & Woods decreased their target price on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Morgan Stanley increased their price target on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Wells Fargo & Company decreased their price target on shares of MetLife from $96.00 to $92.00 and set an “overweight” rating for the company in a research note on Friday, November 7th. Finally, Wolfe Research raised MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.60.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.